These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36729768)
1. Implementation of pharmacogenomics into inpatient general medicine. Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768 [TBL] [Abstract][Full Text] [Related]
2. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals. Ho TT; Gift M; Alexander E Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640 [TBL] [Abstract][Full Text] [Related]
3. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377 [TBL] [Abstract][Full Text] [Related]
4. Patient insights on features of an effective pharmacogenomics patient portal. Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129 [TBL] [Abstract][Full Text] [Related]
5. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine. Schwartz EJ; Issa AM Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals. Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL Intern Med J; 2022 Jul; 52(7):1135-1143. PubMed ID: 35191159 [TBL] [Abstract][Full Text] [Related]
8. Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project". O'Donnell PH; Danahey K; Jacobs M; Wadhwa NR; Yuen S; Bush A; Sacro Y; Sorrentino MJ; Siegler M; Harper W; Warrick A; Das S; Saner D; Corless CL; Ratain MJ Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):68-75. PubMed ID: 24616296 [TBL] [Abstract][Full Text] [Related]
9. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing. Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468 [TBL] [Abstract][Full Text] [Related]
10. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice. Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189 [TBL] [Abstract][Full Text] [Related]
11. Integration of a clinical pharmacist practitioner-led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic. Dreischmeier E; Hecht H; Crocker E; Seckel E; Wilcox A; Fletcher C; Piccolo J Am J Health Syst Pharm; 2024 Sep; 81(19):e634-e639. PubMed ID: 38733328 [TBL] [Abstract][Full Text] [Related]
12. Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing. Siamoglou S; Karamperis K; Mitropoulou C; Patrinos GP J Appl Lab Med; 2020 Sep; 5(5):1005-1016. PubMed ID: 32916714 [TBL] [Abstract][Full Text] [Related]
14. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders. Edris A; Callier E; Lahousse L BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients. Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514 [No Abstract] [Full Text] [Related]
16. Integrating pharmacogenomics into pharmacy practice via medication therapy management. Reiss SM; J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957 [TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing. Russell C; Campion M; Grove ME; Matsuda K; Klein TE; Ashley E; Naik H; Wheeler MT; Scott SA Clin Transl Sci; 2024 Mar; 17(3):e13737. PubMed ID: 38421234 [TBL] [Abstract][Full Text] [Related]
18. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial. Truong TM; Apfelbaum JL; Danahey K; Schierer E; Ludwig J; George D; House L; Karrison T; Shahul S; Anitescu M; Choksi A; Hartman S; Knoebel RW; van Wijk XMR; Yeo KJ; Meltzer DO; Ratain MJ; O'Donnell PH Anesth Analg; 2022 Nov; 135(5):929-940. PubMed ID: 35213469 [TBL] [Abstract][Full Text] [Related]
19. Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science. Dolan ME; Maitland ML; O'Donnell PH; Nakamura Y; Cox NJ; Ratain MJ Pharmacogenomics; 2013 Sep; 14(12):1383-7. PubMed ID: 24024891 [TBL] [Abstract][Full Text] [Related]
20. A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel. Ho TT; Bell G; Gammal RS; Gregornik D; Wake DT; Dunnenberger HM Am J Health Syst Pharm; 2022 Sep; 79(19):1634-1644. PubMed ID: 35876085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]